섬유근통 환자의 통증관리를 위한 통합의학 임상경로 적용: 기존 W 기관 임상경로(Clinical Pathway)에 따른 표준치료군과 통합의학 임상경로(Clinical Pathway)치료군 간의 무작위 대조군 연구
Application of an Integrative Medicine Standard Clinical Pathway for Fibromyalgia Patients: A Randomized Controlled Trial Comparing Standard Treatment and Integrated Medicine Standard Clinical Pathway Treatment Groups
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Fibromyalgia is characterized by chronic pain, fatigue, sleep disturbances, and emotional instability, making it challenging to manage with traditional single-treatment approaches. Conventional medication-based treatments often fail to provide lasting relief and enhance quality of life. This study compares the Integrative Medicine Clinical Pathway (IMCP) to the Standard Clinical Pathway (CP) in terms of pain management and quality of life improvement for fibromyalgia patients. Methods: This single-blind trial involved 26 participants with fibromyalgia, who were randomly assigned to either the CP group (n=13) or the IMCP group (n=13) for a duration of 8 weeks. The IMCP included a combination of acupuncture, pharmacopuncture, counseling, meditation, and yoga. Outcomes were assessed through various measures: pain (Widespread Pain Index [WPI], Symptom Severity Scale [SSS], Numeric Pain Rating Scale [NPRS]), quality of life (EQ-5D, EQ-VAS), emotional state (Coping with Emotions Scale Inventory [CESI]), and sleep quality (Pittsburgh Sleep Quality Index [PSQI]). Results: Participants in the IMCP group demonstrated significant improvements in pain reduction (as measured by SSS and NPRS), quality of life (EQ-5D and EQ-VAS), and emotional stability (CESI) compared to the CP group (p<0.05). However, no statistically significant differences were observed in pain areas (WPI) or sleep quality (PSQI). Conclusions: IMCP effectively reduced pain and enhanced the quality of life for fibromyalgia patients, suggesting its potential as a complementary approach alongside standard treatments. Further large-scale studies and long-term follow-up are needed to confirm these findings.
Abstract
Objectives: Fibromyalgia is characterized by chronic pain, fatigue, sleep disturbances, and emotional instability, making it challenging to manage with traditional single-treatment approaches. Conventional medication-based treatments often fail to provide lasting relief and enhance quality of life. This study compares the Integrative Medicine Clinical Pathway (IMCP) to the Standard Clinical Pathway (CP) in terms of pain management and quality of life improvement for fibromyalgia patients. Methods: This single-blind trial involved 26 participants with fibromyalgia, who were randomly assigned to either the CP group (n=13) or the IMCP group (n=13) for a duration of 8 weeks. The IMCP included a combination of acupuncture, pharmacopuncture, counseling, meditation, and yoga. Outcomes were assessed through various measures: pain (Widespread Pain Index [WPI], Symptom Severity Scale [SSS], Numeric Pain Rating Scale [NPRS]), quality of life (EQ-5D, EQ-VAS), emotional state (Coping with Emotions Scale Inventory [CESI]), and sleep quality (Pittsburgh Sleep Quality Index [PSQI]). Results: Participants in the IMCP group demonstrated significant improvements in pain reduction (as measured by SSS and NPRS), quality of life (EQ-5D and EQ-VAS), and emotional stability (CESI) compared to the CP group (p<0.05). However, no statistically significant differences were observed in pain areas (WPI) or sleep quality (PSQI). Conclusions: IMCP effectively reduced pain and enhanced the quality of life for fibromyalgia patients, suggesting its potential as a complementary approach alongside standard treatments. Further large-scale studies and long-term follow-up are needed to confirm these findings.
참고문헌 (22)
- Cheong MJ, "A Case Study Evaluating the Effectiveness of an Interdisciplinary Team-Based Integrated Medical Service Model in Improving the Quality of Life of a Fibromyalgia Patient and Caregiver through Psychological and Various Counseling Interventions", J of Oriental Neuropsychiatry, 35(2), pp.191~203 (2024)[DOI]
- Clauw DJ, "Fibromyalgia : a clinical review", Jama, 311(15), pp.1547~1555 (2014)[DOI]
- Häuser W, "Validation of the Fibromyalgia Survey Questionnaire within a crosssectional survey", PLoS One, 7(5), pp.e37504~ (2012)[DOI]
- Bennett RM, "Criteria for the diagnosis of fibromyalgia : validation of the modified 2010 preliminary American College of Rheumatology criteria and the development of alternative criteria", Arthritis Care Res(Hoboken), 66(9), pp.1364~1373 (2014)[DOI]
- Carville SF, "EULAR evidence-based recommendations for the management of fibromyalgia syndrome", Ann Rheum Dis, 67(4), pp.536~541 (2008)[DOI]
- Fernandez-Feijoo F, "Quality of life in patients with fibromyalgia : Contributions of disease symptoms, lifestyle and multi-medication", Front Psychol, 13, pp.924405~ (2022)[DOI]
- Ariani A, "The Italian Society for Rheumatology clinical practice guidelines for the diagnosis and management of fibromyalgia Best practices based on current scientific evidence", Reumatismo, 73(2), pp.89~105 (2021)[DOI]
- Geraghty AWA, "Self-management for chronic widespread pain including fibromyalgia : A systematic review and meta-analysis", PLoS One, 16(7), pp.e0254642~ (2021)[DOI]
- Lauche R, "A systematic review and meta-analysis of mindfulnessbased stress reduction for the fibromyalgia syndrome", J Psychosom Res, 75(6), pp.500~510 (2013)[DOI]
- Wolfe F, "Widespread Pain and Low Widespread Pain Index Scores among Fibromyalgiapositive Cases Assessed with the 2010", 2011 Fibromyalgia Criteria, 2016, pp.43(9), 1743~1748
- Wolfe F, "Fibromyalgia diagnosis and diagnostic criteria", Ann Med, 43(7), pp.495~502 (2011)[DOI]
- Bennett R, "The Fibromyalgia Impact Questionnaire(FIQ) : a review of its development, current version, operating characteristics and uses", Clin Exp Rheumatol, 23(5Suppl 39), pp.S154~S162 (2005)
- Hartrick CT, "The numeric rating scale for clinical pain measurement : a ratio measure?", Pain Pract, 3(4), pp.310~316 (2003)[DOI]
- Cheung PWH, "Psychometric validation of the EuroQoL 5-Dimension 5-Level(EQ-5D-5L)in Chinese patients with adolescent idiopathic scoliosis", Scoliosis Spinal Disord, 11, pp.19~ (2016)[DOI]
- Feng Y, "Assessing the performance of the EQ-VAS in the NHS PROMs programme", Qual Life Res, 23(3), pp.977~989 (2014)[DOI]
- Kim JS, "A Study on the Validation and Standardization of the CSEI-s (The Core Seven Emotions Inventory–short form)", Doctor, pp.2023
- Sohn SI, "The reliability and validity of the Korean version of the Pittsburgh Sleep Quality Index", Sleep Breath, 16(3), pp.803~812 (2012)[DOI]
- Lee S, "PS223. Validation of the Korean version of Center for Epidemiologic Studies Depression scale-Revised", Int J Neuropsychopharmacol, 19(Suppl 1), pp.81~82 (2016)[DOI]
- Bernardy K, "Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome-A systematic review and meta-analysis of randomized controlled trials", Eur J Pain, 22(2), pp.242~260 (2018)[DOI]
- Häuser W, "Emotional, physical, and sexual abuse in fibromyalgia syndrome : a systematic review with meta-analysis", Arthritis Care Res(Hoboken), 63(6), pp.808~820 (2011)[DOI]
- Badanta B, "Complementary and Alternative Medicine to Treat Fibromyalgia Symptoms. A Systematic Review", J Pain Res, 17, pp.1709~1723 (2024)[DOI]
- Kundakci B, "International, multidisciplinary Delphi consensus recommendations on non-pharmacological interventions for fibromyalgia", Semin Arthritis Rheum, 57, pp.152101~ (2022)[DOI]